Results 81 to 90 of about 4,695 (214)

A retrospective analysis of the antigen‐negative red blood cell supply conducted at a single centre in China

open access: yesTransfusion Medicine, EarlyView.
Abstract Objective This study aimed to analyse the distribution and demand patterns of antigen‐negative red blood cells (RBCs) in Shandong Province, China (2022–2024), with a focus on ABO blood groups and clinically significant antigens. The research was designed to provide rigorous data for advancing precision transfusion protocols and to establish a ...
Aiping Zhao   +7 more
wiley   +1 more source

Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins

open access: yes, 2015
Allo-anti-M often has an immunoglobulin G (IgG) component but is rarely clinically significant. We report a case of hemolytic disease of the fetus and newborn along with prolonged anemia in newborn twins that persisted for up to 70 days postbirth.
Satyam Arora   +4 more
core   +1 more source

Free Fetal DNA Testing to Guide Early Intervention in the Management of the Kell Alloimmunized Pregnancy

open access: yes
Prenatal Diagnosis, EarlyView.
Kenneth J. Moise Jr   +3 more
wiley   +1 more source

Simple image analysis for reliability control of column agglutination test in pretransfusion testing

open access: yesTransfusion Medicine, EarlyView.
Abstract Objectives A novel meniscus‐based analysis provides a rapid method to identify analytical errors related to unrecognised pipetting errors. Background The indirect antihuman globulin test (IAT) is part of pretransfusion testing, enabling detection of erythrocyte alloantibodies.
Martin Töffner Pedersen   +5 more
wiley   +1 more source

Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn

open access: yes, 2017
Common causes of fetal anemia and hydrops include parvovirus B19 infection during the first 2 trimesters of pregnancy, as well as maternal alloimmunization to RhD with subsequent hemolytic disease of the fetus and newborn (HDFN) in an RhD positive fetus.
Edwina J Popek, Whitney A McCarthy
core   +1 more source

Intravenous immunoglobulin as an adjunct to phototherapy in neonatal haemolytic disease: A systematic review and meta‐analysis

open access: yesTransfusion Medicine, EarlyView.
Abstract Phototherapy remains the first‐line treatment of haemolytic disease of the newborn (HDN), a potentially life‐threatening condition caused by maternal alloimmunisation. Intravenous immunoglobulin (IVIG) has been proposed as an adjunct to reduce the need for exchange transfusion (ET), a procedure associated with significant risks.
Megan Roberts   +11 more
wiley   +1 more source

A PIGG congenital disorder of glycosylation (PIGG‐CDG) variant associated with an Emm− red blood cell phenotype in a pediatric patient

open access: yesTransfusion, EarlyView.
Abstract Background The high‐prevalence Emm antigen is an epitope on the GPI (glycosylphosphatidylinositol) glycolipid backbone, which anchors proteins to the cell surface. Inherited loss‐of‐function of PIGG (or PIGO) results in the rare Emm− red cell (RBC) phenotype and is associated with congenital disorders of glycosylation (CDG).
Alastair Murray   +8 more
wiley   +1 more source

Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion

open access: yesTransfusion, EarlyView.
Abstract Background As prehospital transfusion becomes more common in the United States (US), cases of hemolytic disease of the fetus and newborn (HDFN) might increase. This study forecasted the number of HDFN cases in 2029 resulting from RhD‐positive prehospital transfusions. Study Design and Methods A regression was performed on the number of females
Adnan S. Syed   +6 more
wiley   +1 more source

HLA‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply

open access: yesTransfusion, EarlyView.
Abstract Background Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA‐antibody screening was implemented in different strategies.
Emilie A. Jochumsen   +6 more
wiley   +1 more source

Impact of nationwide parvovirus B19 DNA screening and identification of transfusion‐transmitted infections

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Parvovirus B19 (B19V) testing is often not required to release blood components. However, the European Pharmacopoeia requires that plasma pools for fractionation contain no more than 104 IU/mL of B19V DNA. In France, pool B19 nucleic acid testing (NAT) screening was performed by Établissement Français du Sang since ...
Virginie de la Taille   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy